Natus Medical Inc (NasdaqGS:BABY) agreed to acquire GN Otometrics A/S from GN Store Nord A/S (CPSE:GN) for $145 million on September 25, 2016. The total consideration payable will be settled in cash on a debt and cash free basis. As part of the transfer of ownership of GN Otometrics, GN Store Nord A/S (CPSE:GN) and Natus Medical Inc (NasdaqGS:BABY) have entered into a strategic partnership to collaborate on future technology, product development and commercialization. Additionally, the world's first complete digital ear scanning solution, OTOSCAN, will be fully commercialized by Natus with future royalties to GN Hearing. Natus also announced that it has entered into a $150 million revolving credit agreement with JP Morgan Chase, N.A. and Citibank, N.A. Natus will use offshore cash and proceeds from this credit line to fund the acquisition. GN Otometrics reported annual revenues of approximately $110 million. The closing of the transaction is subject to regulatory approval. The deal is expected to close by end of 2016. PwC Corporate Finance acted as financial advisor to GN Store Nord A/S. Kathleen Lemmens, Pietro Vitale and Ilaria Fagnani of Gianni Origoni Grippo Cappelli acted as the legal advisor for Natus Medical. Fabrizio Scaparro, Andrea Bartolucci and Paola Cairoli of Giovannelli e Associati acted as the legal advisor for Gn Hearing. Bent Kemplar, Jette Hessellund Lauridsen, Morten Kofmann and Michael Nørremark of Kromann Reumert acted as legal advisors to Natus Medical Incorporated. Moalem Weitemeyer Bendtsen acted as legal advisor to GN Hearing A/S.



Natus Medical Inc (NasdaqGS:BABY) completed the acquisition of GN Otometrics A/S from GN Store Nord A/S (CPSE:GN) on January 3, 2017.